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Abstract
Orofacial malformations resulting from genetic and/or environmental causes are frequent human birth defects yet their
etiology is often unclear because of insufficient information concerning the molecular, cellular and morphogenetic
processes responsible for normal facial development. We have, therefore, derived a comprehensive expression dataset for
mouse orofacial development, interrogating three distinct regions – the mandibular, maxillary and frontonasal
prominences. To capture the dynamic changes in the transcriptome during face formation, we sampled five time points
between E10.5–E12.5, spanning the developmental period from establishment of the prominences to their fusion to form
the mature facial platform. Seven independent biological replicates were used for each sample ensuring robustness and
quality of the dataset. Here, we provide a general overview of the dataset, characterizing aspects of gene expression
changes at both the spatial and temporal level. Considerable coordinate regulation occurs across the three prominences
during this period of facial growth and morphogenesis, with a switch from expression of genes involved in cell proliferation
to those associated with differentiation. An accompanying shift in the expression of polycomb and trithorax genes
presumably maintains appropriate patterns of gene expression in precursor or differentiated cells, respectively.
Superimposed on the many coordinated changes are prominence-specific differences in the expression of genes encoding
transcription factors, extracellular matrix components, and signaling molecules. Thus, the elaboration of each prominence
will be driven by particular combinations of transcription factors coupled with specific cell:cell and cell:matrix interactions.
The dataset also reveals several prominence-specific genes not previously associated with orofacial development, a subset
of which we externally validate. Several of these latter genes are components of bidirectional transcription units that likely
share cis-acting sequences with well-characterized genes. Overall, our studies provide a valuable resource for probing
orofacial development and a robust dataset for bioinformatic analysis of spatial and temporal gene expression changes
during embryogenesis.
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Introduction
The face provides an important template for integrating major
sensory inputs from the mouth, nose, eyes, and ears that are then
relayed to the adjacent brain. The development and evolution of the
face and jaws has been a major driving force in the expansion of
vertebrate lineages over recent geological times. Paired jaws have
served as critical components for adaptive radiation, and variation in
jaw design between species has generated many different vertebrate
facial morphologies [1]. Moreover, for humans and many other
species, the face provides a fundamental aspect of a person’s
individuality, acts as a major component of sexual selection, and
servesasthevesselthroughwhichouremotionsarerelayedtoothers.
Although some growth of the face occurs post-natally, the basic
facial pattern is generated during embryogenesis by a complex set
of tissue interactions and morphogenetic processes (for reviews see
[2,3,4]). Growth and patterning of the face relies on several small
buds of tissue, the facial prominences, which surround the
primitive mouth. These prominences consist of swellings of
mesenchyme that are encased in an overlying epithelium. The
mammalian upper jaw is derived from six main prominences: two
central medial nasal processes, flanked by paired lateral nasal and
maxillary prominences. The lateral and medial nasal prominences
are components of the frontonasal mass, while the maxillary
prominence is derived from tissue rostral to the first branchial
arch. The lower jaw originates from a pair of mandibular
prominences, each derived from the first branchial arch.
Beginning around E10 of mouse development, the prominences
undergo rapid growth and morphogenesis. By E11.5 the paired
medial nasal prominences are in close apposition in the midline,
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side of the developing face. By E12.5 the nasal and maxillary
prominences fuse to form a continuous shelf at the front of the face
- the primary palate. The formation of the secondary palate from
outgrowths of the maxillary prominences is a separate develop-
mental process that occurs later, between E12-E15.5 of mouse
embryogenesis [5].
The interaction of at least five tissues is vital for the formation of
the face: neural crest cells (NCCs), paraxial mesoderm, the neural
tube, the foregut endoderm, and the facial ectoderm [2,4]. The
first two tissues form most of the facial skeleton, connective tissue,
and muscle. In combination with the latter three tissues they also
supply growth factors and signaling molecules needed for the
appropriate growth and patterning of the facial skeleton. NCCs
from the hindbrain region form ganglia and skeletal derivatives
associated with the branchial arches, including the mandible and
hyoid bones. NCCs from the midbrain and forebrain regions form
a major component of the frontonasal mesenchyme. These
forebrain and midbrain NCC populations will form the cartilage,
bone and connective tissue of the face, while the musculature will
be derived from the contribution of paraxial mesoderm to the
facial mesenchyme.
Concomitant with these morphogenetic processes, a number of
growth, differentiation, and patterning events also occur. Some
events, such as the development of the cartilage and bone of the
craniofacial skeleton, are shared among all the facial prominences.
In other instances, individual prominences are associated with
specific developmental processes, and this is reflected by patterns
of differential gene expression that give the prominences their
unique identities. Thus, the mandibular and maxillary promi-
nences give rise to dentition, the frontonasal prominence has a
unique role in olfaction, and the mandibular prominence in taste.
Reflecting the complexity of facial development, orofacial
defects are among the most frequent human congenital malfor-
mations [6,7,8]. Cleft lip with or without cleft palate (CL/P) occurs
in approximately 1 per 1000 live births in North America. Lateral
clefts in CL/P are caused by failure of the lateral nasal and
maxillary prominences to fuse and may be either unilateral or
bilateral. CL/P can also occur in the facial midline due to a failure
in the fusion of the two medial nasal prominences at the ventral
midline. Cleft secondary palate (cleft palate; CP) results from
aberrant formation, morphogenesis, and fusion of the maxillary
prominence-derived palatal shelves at a slightly later stage of
orofacial development. In addition to clefts, a number of other
rare birth defects involve abnormal growth of the underlying
craniofacial skeleton [9].
Orofacial clefts and other craniofacial malformations have clear
environmental and genetic causes. However, insufficient informa-
tion exists concerning the mechanisms of orofacial development to
detect or prevent the majority of these defects pre-natally. In this
context, the identification and characterization of the genes
expressed during embryonic facial development will provide
valuable insight into the molecular and cellular interactions
governing this process. Here, using the mouse as a model system,
we have employed gene expression profiling to study the pathways
involved in face formation. We focused on the cellular and
molecular changes occurring in the developing mouse face
between E10.5–E12.5 during which the facial prominences
undergo dynamic growth, morphogenesis and fusion to form the
basic platform of the face. Determining the molecular mechanisms
driving face development during this period provides a critical
framework for understanding the genetic and environmental
causes of human orofacial clefting as well as other facial
dysmorphologies.
Materials and Methods
Study Design
All animal experiments were performed in accordance with
protocols approved by the University of Colorado Denver (UCD)
Animal Care and Usage Committee. Our analysis focused upon
Theiler stages (TS) 17–20.3, which are equivalent to E10.5–E12.5
of mouse embryonic development. This time-span is the most
relevant to the development of human orofacial clefts, and also
marks the period in which initial differentiation and morphogen-
esis of the craniofacial skeleton occurs [3,10,11]. The earliest time
point (E10.5) corresponds to when all three facial prominences can
first be distinguished alongside the olfactory pits (TS17). The final
time point (E12.5) is when the individual prominences are about to
initiate fusion to form the primary palate after which they cannot
be distinguished as discrete entities (TS20.3). Facial growth and
morphogenesis is rapid during this period so samples were isolated
at 0.5-day intervals to capture dynamic changes in gene
expression.
The inbred C57BL/6J strain (Jackson Labs) was chosen for
analysis to reduce genetic variation among samples and select
changes in gene expression that result more from temporal- and
spatial-specific differences. Moreover, the most extensive staging
classification for development of the mouse face is based on this
strain [10]. Following mating and visualization of a vaginal plug,
pregnant females were sacrificed between E10.5 and E12.5. Mice
employed for the E11, and E12 time points were housed in a
reverse light cycle room to facilitate dissections at midday for all
samples. Embryos were dissected from the uterus in ice-cold
phosphate buffered saline solution (PBS) and then individually
placed into drops of PBS in a petri dish. Embryos were staged by
examination of somite numbers and craniofacial features (Table 1)
and embryos conforming to the criteria for the 0.5-day interval
under analysis were pooled. Pooling was necessary to obtain
sufficient RNA for screening of the microarrays and also smoothes
out variations between individual samples. The alternative, using
fewer embryos but then incorporating a PCR amplification step,
would potentially introduce considerable skewing and bias into the
analysis. Table 1 indicates the number of embryos required at the
various time points to obtain sufficient RNA for each prominence
to be used for one microarray screening experiment. A schematic
overview of the dissection process is shown in Figure 1.
After staging, embryos were bisected with forceps at the level of
the heart and the caudal portion was discarded. Tungsten needles
were employed to isolate the combined maxillary and mandibular
prominences and these were then separated into their individual
Table 1. Staging criteria for assignment of embryos to
particular timepoints and corresponding RNA yields.
TS = Theiler stage.
Timepoint Staging Criteria
Number of embryos
needed for .5 mg
total RNA from
each prominence
E10.5 TS 17 (lens vesicles form deep pockets) 24–28
E11.0 TS 18 (three hyoid auricular hillocks) 8–9
E11.5 TS19 (nares narrow to small slits) 8–9
E12.0 TS 20.1 (tongue begins to form) 3–4
E12.5 TS 20.3 (mandibular arch and the first
hyoid auricular hillock begin to fuse)
3–4
doi:10.1371/journal.pone.0008066.t001
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were removed from the remainder of the head. Briefly, an incision
was made in the ectoderm overlying the prominences to produce a
flap of ectoderm that was peeled back with the loosely aggregated
cells of the mesenchyme still attached. Note that if the cut was
made too deep and extended into the forebrain region, loosely
packed mesenchymal cells were no longer visible. Samples that
were potentially contaminated with forebrain tissue were discard-
ed. Suitably pure maxillary (MxP), mandibular (MdP), and
frontonasal (FNP) samples were placed in separate tubes
containing RNAlater (Ambion) and stored at 220uC for
subsequent pooling and processing.
RNA preparation and quality assessment
Tissue pools were dissolved in 1 ml Trizol (Invitrogen) and total
RNA was extracted according to the manufacturer’s instructions
and resuspended in a final volume of 100 ml DEPC-treated water.
Subsequently, the sample was further purified using the RNeasy
Mini Kit (Qiagen, Inc.). The concentration of each total RNA
sample was determined from absorbance at 260 nm (A260) and
the quality of each sample was determined based on the ratio of
A260 to A280. Samples with a ratio between 1.9–2.1 were
considered adequately pure for cDNA synthesis. Prior to
microarray analysis, individual samples were assayed using RT-
PCR to ensure RNA integrity, purity, and expression of transcripts
appropriate for the particular prominences. 1–2 mg total RNA was
used for cDNA synthesis using random primers and Superscript
III reverse transcriptase (Invitrogen) according to the manufac-
turer’s instructions. Subsequently, 2 ml of the cDNA mixture was
used for PCR in a 25 ml reaction with Accuprime Taq DNA
polymerase (Invitrogen) using the following conditions: 1 cycle at
94uC for 3 min; 35 cycles at 94uC for 45 sec, 58uC for 45 sec,
68uC for 1 min; and 1 cycle at 68uC for 10 min. Specific primers
(Table S1) were directed against transcripts diagnostic for the
facial prominences. Representative RT-PCR results demonstrated
the presence of transcripts corresponding to expression of the
marker genes Tcfap2a (GeneID: 21418), Bmp2 (GeneID: 12156),
Dlx2 (GeneID: 13392), and Gsc (GeneID: 14836) in the FNP and
MxP prominences, as expected (Figure S1). We also analyzed the
prominence tissues for transcripts that would indicate significant
contamination from surrounding tissues, particularly the presence
of adjacent CNS tissue within our FNP samples e.g. Zic3 (GeneID:
22773) for forebrain tissue (Figure S1). Contaminated or degraded
RNA samples were discarded.
Microarray hybridization and data capture
Microarray analyses were carried out by the UCD Gene
Expression Core Facility. Total RNA (2–5 mg) was converted to
double-stranded cDNA (ds-cDNA) using the Superscript Choice
System (Life Technologies, Inc.) and an oligo-dT primer
containing a T7 RNA polymerase promoter (Genset Corp.).
Subsequently, the reaction mixture was extracted with phenol:
chloroform:isoamyl alcohol and the ds-cDNA was recovered by
ethanol precipitation. In vitro transcription (IVT) was performed to
generate biotin-labeled cRNA using an RNA Transcript Labeling
Kit (Enzo. Inc.) and 3.3 mL ds-cDNA template in the presence of a
mixture of biotin-labeled ribonucleotides. Biotin-labeled cRNA
was then purified using an RNeasy affinity column (Qiagen) and
the cRNA was fragmented to ensure optimal hybridization to the
oligonucleotide array. Fragments between 35–200 bp in length
were generated by incubating the cRNA at 94uC for 35 min in a
fragmentation buffer. The quality of total RNA, labeled cRNA
and fragmented cRNA were assessed using an Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA). Only samples
that passed all tests of quantity and quality were used for
hybridization to microarrays. The sample was then added to
200 ml of hybridization solution containing 100 mM MES, 1 M
NaCl, and 20 mM EDTA in the presence of 0.01% Tween 20 to
give a 0.05 mg/mL final concentration of fragmented cRNA. Next,
the cRNA was hybridized to Affymetrix GeneChipH Mouse430
2.0 microarrays, which contain probes corresponding to 39,000
mouse transcripts, at 45uC for 16 hr in a GeneChipH Hybridiza-
tion Oven 640 (Affymetrix, Santa Clara, CA.). The microarrays
were washed and stained using an Affymetrix Fluidics Station 450
according to the manufacturer’s standard protocol and scanned
using the Affymetrix GeneChip Scanner 3000 (Affymetrix). Raw
image data from array scans was processed in the GeneChipH
Operating Software (Affymetrix) using the option in which a
scaling factor was applied to bring the average intensity for all
probes on the array to the same target intensity value (TGT) of
500. This normalization allowed samples to be compared across
arrays. All data from our analysis are MIAME compliant, and the
raw data (non-log2 transformed) are available via GEO (http://
www.ncbi.nlm.nih.gov/geo) with the accession number GSE7759.
In situ hybridization
We amplified genes chosen for verification analysis from total
RNA by RT-PCR using primer pairs (Table S1) as described
above. Subsequently, the products were cloned using Zero Blunt
TOPO vector methodology (Invitrogen) and sequenced to confirm
identity. Digoxigenin-UTP labeled probes were generated from
linearized plasmids with either T7 or SP6 RNA polymerase
(Roche). Whole-mount in situ hybridization was then performed
essentially as described using staged C57BL/6J embryos [12].
Briefly, mouse embryos were fixed overnight in 4% PFA
(paraformaldehyde) at 4uC, dehydrated in a graded series of
methanol buffered with PBT (PBS containing 0.1% Tween 20)
and stored at 270uC in 100% methanol. After rehydration,
embryos were incubated overnight at 70uC in 1 ml hybridization
buffer (50% formamide, 5X SSC, 50 mg/ml yeast tRNA, 1% SDS,
50 mg/ml heparin and 1 mg digoxigenin-labeled sense or anti-
sense probe). After washing to remove unhybridized RNA probe,
AP-conjugated (alkaline phosphatase) anti-digoxigenin antibody
(Roche) was used to detect the digoxigenin-labeled RNA probe.
BM purple AP substrate (Roche) was used for colorimetric
Figure 1. Isolation of the mouse facial prominences. Graphic
representation of the embryonic mouse head illustrating the facial
tissues collected for analysis.
doi:10.1371/journal.pone.0008066.g001
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(Diagnostic Instruments) and processed using Adobe Photoshop.
Data filtering
To improve statistical power in light of necessary corrections for
multiple testing, two filters were first applied to the dataset to
discard probe sets that did not vary across any of the conditions.
The first filter, the median filter [13,14], discarded probe sets
whose standard deviation across all 105 samples - using the
GeneChipH Operating Software (Affymetrix) Signal values - was
less than, or not significantly different than, the median standard
deviation, leaving 20,868 of the original 45,101 probe sets.
Selection of the median variance as a cutoff is based on the
assumption that fewer than half of the genes in the genome are
involved in orofacial development. The second filter removed a
further 634 probe sets with a Detection call of ‘Absent’ across all
105 samples. The remaining 20,234 probe sets formed the input
dataset for further statistical testing.
Statistical differences of expression
Statistically significant differential expression between any two
samples was tested using the limma package [15] of Bioconductor
[16] on the log2-transformed Signal data. The limma package uses
an empirical Bayes approach to create a moderated t-statistic by
shrinking the estimated sample variances towards a pooled estimate
thereby allowing more stable inference than an ordinary t-statistic
when thesamplesize issmall.P-values werecalculatedforeachtime
point among different prominences (12 in total) as well as among
adjacent pairs of time points for each prominence (30 in total). For
allanalyses,thefalsediscoveryratewassetto1%withtheadditional
requirement of at least a 2-fold change to be deemed significant
(setting fdr=0.01 and lfc=1 in the decideTests function).
Differential expression across the entire time series was
characterized by the trajectory clustering algorithm [14]. In lieu
of ANOVA or Kruskal-Wallis p-values used by the original
algorithm, the moderated t-statistic p-values from limma were
used with a threshold of 0.05 (retaining the requirement for at least
2-fold change).
Functional category analysis
Probe sets were mapped to MGI identifiers using information
from the Affymetrix netaffx web interface (downloaded 18
th Dec
2007). Each MGI was then mapped to terms from: the Gene
Ontology (GO) Biological Process and Molecular Function
ontologies [17] using the association file available from the GO
website (downloaded 11 May 2007); InterPro categories [18] using
the MRK_InterPro.rpt file from the Jackson Laboratory website
(downloaded 22 Aug 2006); the Mammalian Phenotype Ontology
(MP) terms using the MGI_PhenoGenoMP.rpt file from the
Jackson Laboratory website (downloaded 10 Oct 2006) and; the
Kyoto Encyclopedia of Genes and Genomes (KEGG) [19]
pathways using the mapping files from the KEGG website
(downloaded 20 June 2007). Over-representation of each term
was tested using the binomial distribution (an efficiently comput-
able and close approximation to the hypergeometric distribution
when the number of items to choose among is large [20]). P-values
were adjusted using the false discovery rate (fdr) multiple
comparison correction [21] and setting the threshold to 0.05.
Results
The Facial Transcriptome
A comprehensive, high-quality gene expression dataset was
derived for mouse orofacial development by sampling the
mandibular (MdP), maxillary (MxP) and frontonasal (FNP) facial
prominences at 0.5-day intervals from E10.5-E12.5, after which
point the prominences fused and were no longer separate entities.
Seven independent biological replicates were used for each
sample, which provided very strong statistical power - a false
reading should only be obtained at the rate of 0.06%. In the
remainder of the results, we first assess the numerical and
biological quality of the dataset. We then provide an overview of
gene expression profiles for genes involved in key biological
processes, such as cell cycle regulation, and transcription. Lastly,
we describe the identification of several genes which either: 1) had
not been linked with orofacial development previously, but had
been studied in the context of other biological systems; or 2) had
little or no prior functional information available, but for which
the dataset now suggested a role in orofacial development.
Overview of the Expression Data and Data Quality
Assessment
Determination of the number of genes expressed in the dataset
was based upon the Detection calls made by the Affymetrix analysis
software and any ‘‘non-Absent’’ calls were considered in the
expressed category. Using this criterion, more than 20,000 probes
were expressed during the period of face formation from E10.5–
E12.5. Of 45,101 total probes on the Affymetrix Mouse 430 2.0
microarray, 30% had detectable expression in all 105 samples while
47% were undetectable in any sample. In terms of spatial
distribution, 80–82% of the expressed sequences were detected in
all three regions of the developing face (Figure 2). A more limited
number of probes were expressed in only one prominence or were
shared between two of the three prominences (Figure 2). In addition
to expression defined by Detection calls, a stringent assessment of
prominence-specific expressionwasobtained byapplying the limma
Figure 2. Gene expression during mouse facial development. Venn diagrams showing the number of genes expressed (called Present or
Marginal) in the three facial prominences at the five developmental time points analyzed. Values represent the number of probes on the Affymetrix
Mouse 430 2.0 array detected by the software in all seven replicates, i.e., called Present or Marginal using the GeneChip Operating Software.
doi:10.1371/journal.pone.0008066.g002
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point. Of 20,234 probes tested, 1,506 displayed at least one
statistically significant difference between prominences for a given
time point. The minimum observed was 171 differences between
the MdP and MxP at E10.5, with a maximum of 646 differences in
sequence intensitybetweenMdP and FNPat E12.5 (Figure S2A). In
general, an increasing number of differences occurred between
individual prominences at each successive time point consistent with
a divergenceoffunctionaccompanied bygreatercomplexityofgene
expression (Figure S2A). The greatest number of statistically
significant prominence-specific gene expression differences oc-
curred between the MdP and FNP, and the least between the
MdP and MxP, at all time points. With respect to temporal changes
ingene expression,1,328probesets displayedatleastonesignificant
increase or decrease between adjacent time points within a
particular prominence. This ranged from a minimum of 44
significant changes for the FNP between E11.5 and E12.0, to 582
differencesfortheMxPbetween E11.0and E11.5(Figure S2B).The
data potentially illustrate both an earlier onset of significant gene
expression changes in the MdP and circadian aspects to the changes
that are occurring in the three prominences. A more in-depth
characterization of genes differentially expressed over the entire
time series is given later in this section.
Reproducibility of the qualitative Detection calls, namely Absent,
Marginal and Present, were assessed using the kappa statistic which
measuresagreementamongcategoricalvariables[22]withexcellent
reproducibility denoted by kappa values .0.75. The median kappa
value among replicates was 0.7938 (min=0.65, max=0.84).
Relatively high kappa values also occurred among non-replicates
(median=0.7649, min=0.58, max=0.83) indicative of consider-
able similarity in global gene expression across the three
prominences at all time points. This latter finding suggested that
there were unlikely to be widespread radical differences in gene
expression between the prominences over the time course of the
analyses. Instead, the data was more consistent with subtle
alterations in the expression of multiple genes potentially coupled
with extensive differences in a limited set of transcripts.
Reproducibility of the quantitative Signal values was assessed
using the coefficient of variation (CV), defined as the ratio of the
standard deviation to the mean [22]. The CV is zero for perfect
reproducibility while higher values indicate poorer reproducibility.
If the CV is close to 1, the variability of measurement is on the
same scale as the signal and no meaningful analysis is possible
[23]. In our dataset the median CV was 0.30 among replicates
(min=0.01, max=2.59), calculated over all probes in all
prominence- and time-specific replicate groups (Figure 3). Much
of the high variability was attributable to probes called Absent in
all 105 samples (Figure 3, inset), an important distinction since
data for all-Absent probes were removed in any further analyses.
Disregarding those probes called Absent in all samples, the median
CV dropped from 0.30 to 0.24, versus CV=0.59 among all-
Absent probes. The dramatic effect seen when distinguishing
among probes based on Absent calls highlights not only the
benefits of incorporating the Detection information, but also the
importance of utilizing the kappa statistic to assess the quality of
that Detection information. High quality of replication in terms of
the mean and standard deviation among replicates for each
sample was also observed (Figure S3).
Biological Verification of the Dataset
For initial biological verification we focused on genes with
established prominence-specific expression patterns such as Hand2
Figure 3. Coefficient of variation (CV) analysis demonstrates high quality of the dataset. The main graph illustrates the CV distribution for
all probes tested. In the inset graph, the data are represented by the brown line. Removal of the ‘‘probes all absent’’ calls (black line), which show
greater signal variation, indicates that the ‘‘Present’’ and ‘‘Marginal’’ probes have even greater reproducibility, illustrated by the shift in the CV curve.
doi:10.1371/journal.pone.0008066.g003
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and members of the Dlx family [24,25,26,27]. There was excellent
agreement between our microarray data (Figure 4A and B) and
the expression patterns of these genes as previously determined by
whole mount in situ hybridization analysis (WMISH). Thus, the
microarray data demonstrated that Dlx1 (GeneID: 13390), Dlx2
and Lhx8 (also known as Lhx7) were preferentially expressed in the
MdP and MxP (Figure 4A and B) in agreement with published
WMISH results [25,26]. Previous data had also documented that
Dlx3 (GeneID: 13393), Dlx4 (GeneID: 13394), Dlx5 (GeneID:
13395) and Dlx6 (GeneID: 13396) were expressed most highly in
the MdP, and this was again reflected at the earlier time points in
Figure 4. Biological verification of the dataset. (A). Raw data for the prominence-specific genes and associated probe sets (left) indicated at the
five time points in the three prominences. (B). Corresponding heatmap for the prominence-specific genes and associated probe sets. The heatmaps
show the expression data for each probe scaled such that the vector of log2 expression values for a probe (averaged among replicate samples per
time point) has a mean of zero and a magnitude of one. Red and blue indicate high and low expression, respectively.
doi:10.1371/journal.pone.0008066.g004
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also detectible for these latter four Dlx genes in the FNP and MxP,
a finding that was consistent with in situ hybridization data ([26]
and data not shown). A similar concordance was found between
our data and the WMISH expression patterns for Hand2 (also
known as dHand) a gene that was expressed strongly in the MdP,
but not in the MxP and FNP (Figure 4A and B). We chose Elavl4
(Hud) as a marker that should be enriched in the FNP as this gene
is associated with neurogenesis and is expressed in the developing
olfactory epithelium of the nasal pit [27]. The microarray data
again reflected appropriate FNP-specific expression for Elavl4
(Figure 4A and B). Elavl4 is also strongly expressed in the
developing peripheral nervous system, including the trigeminal
ganglia, but we did not detect significant levels of Elavl4 expression
in our MdP and MxP samples until E12. This finding provided
additional evidence that our prominence samples were not heavily
contaminated with surrounding craniofacial tissue. Thus, our
dissections produced prominence specific material, and there was
an excellent correspondence between our microarray findings and
established differential gene expression patterns.
Functional Category Analysis of the Temporal Expression
Differences
Analysis of over-represented terms among probes with temporal
expression differences supported a model in which processes such as
cell metabolism and cell growth were declining while differentiation
was increasing. Alterations in expression between adjacent time points
across the entire time series were characterized using the trajectory
clustering algorithm [14]. This approach generates a set of direction
change labels between adjacent time points, namely increased, flat, or
decreased expression, that can then be extended into a more
informative matrix by including all time points. Data collection at five
time points generated a total of 81 possible trajectories for each
prominence (Table S2). The majority of probes, 15,510 out of 20,234
tested, exhibited consistently flat profiles (no changes) across all five
time points in the three prominences. The remaining set of 4,724
probes showing differential expression over time in at least one
prominence was much larger than the set of 1,323 probes found using
l i m m aa l o n eo na d j a c e n tt i m ep o i n t s ,s i n c et r a j e c t o r yc l u s t e r i n g
captures changes that unfold over longer periods of time.
Our initial analysis concentrated on trajectories with predom-
inantly upward or downward trends. Examination of the
trajectories showing at least two decreases and no increases over
the time course revealed a broad and statistically significant down-
regulation of genes involved in cell division and general
metabolism in all three prominences between E10.5–E12.5
(Figure 5 and Tables S3A-J). Seven functional categories
associated with cell motility, amino acid metabolism, and other
metabolic processes showed a consistent 2-fold reduction in
expression during the time course while genes involved with cell
cycle, splicing, and translation showed analogous declines in the
expression, although less than 2-fold (Figure 5).
Across the prominences, ,28% of the down-regulated genes
were involved in protein metabolic processes, 16% in biosynthetic
Figure 5. Functional analysis of trajectories: selected categories showing at least two decreases and no increases over the time
course. Over-represented terms, reaching significance at fdr =0.5 for the binomial distribution, were based on probes achieving limma statistical
significance. Those shown in bold and labeled ‘‘(2FC)’’ reach the additional criterion of a 2-fold change in gene expression.
doi:10.1371/journal.pone.0008066.g005
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translation, 11% in the cell cycle, and 3% in nucleocytoplasmic
transport. With respect to individual categories, 25–35% of the
genes assigned to glucose metabolism, nucleotide metabolism,
DNA replication, DNA repair, RNA processing, amino acid
activation, and nucleocytoplasmic transport were found to
decrease in expression in the three prominences. Certain terms,
including DNA replication initiation, did show a wider range of
the percentage of affected genes (Table S3E). The variation in the
number of down-regulated genes within such categories may
indicate subtle differences in developmental programs among the
prominences. Similarly, the assignment of particular terms to
individual prominences - or to two of the three prominences -
highlights further pathways that may contribute to differential
development (Figure 5). In general, though, the relatively small
magnitude of the observed gene expression decreases, and the
broad range of metabolic functions involved likely reflect an
equivalent slowing of growth across all three prominences rather
than a drastic change in basic cellular processes.
Conversely, for genes showing an upward trend in expression
for at least two of the four intervals and no decreases, the over-
represented terms reflected differentiation (Figure 6 and Tables
S3K-U). These increases were more robust, and consistently
exceeded the criterion of a 2–fold change in the level of expression.
Prominent categories displaying expression increases in all three
prominences included cell adhesion, cell migration, and cell
morphogenesis. Categories for transcription factors, cell signaling,
protein interaction domains, calcium-dependent processes, and
the extracellular matrix were also highlighted in the various
prominences. Notably, ,50% of the genes associated with
phosphate transport showed increasing expression in all promi-
nences (Table S3Q), many by more than 2-fold (Table S3K).
Genes showing an upward trend in expression reflected tissue
specialization into teeth, cartilage, and nervous system compo-
nents with prominence-specific categories more evident than in the
gene sets showing decreased expression (Figure 6 compared with
5). In particular, the MdP exhibited increased expression of genes
associated with various muscle differentiation categories, reflecting
tongue development. The MdP was also over-represented for
terms associated with tube morphogenesis and epithelial cell
differentiation, presumably reflecting development of the taste
buds, teeth, and salivary glands (Figure 6). In contrast, genes
Figure 6. Functional analysis of trajectories: selected categories showing at least two increases and no decreases over the time
course. Over-represented terms, reaching significance at fdr =0.5 for the binomial distribution, were based on probes achieving limma statistical
significance. All reach the additional criterion of a 2-fold change in gene expression.
doi:10.1371/journal.pone.0008066.g006
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nucleotide dependent protein kinase signaling were apparent in
the MxP. The FNP was enriched for genes associated with
sulfotransferase activity and skeletal development. The MdP,
MxP, and FNP were also distinguished by the different protein
motifs and protein:protein interaction domains that the trajectory
clustering analysis highlighted in the three prominences (Figure 6).
We present a further analysis of prominence specific differences in
the next section.
In addition to the generally upward or downward gene
expression profiles, the trajectory clustering analysis also high-
lighted several other terms that were over-represented in specific
trajectories within a given prominence (Table S2). Two broad
themes can be identified from these additional profiles. First,
categories in GO Molecular Function, and Biological Process
ontologies associated with oxidative phosphorylation showed
fluctuating trajectories (up and down) in all three prominences.
This finding suggests that energy generation during this period of
embryogenesis displays periodicity, consistent with a circadian
rhythm that may reflect the nocturnal activity of the mother.
Second, ontological terms containing the words ‘‘histones’’ or
‘‘chromatin’’ also had fluctuating trajectories, potentially indicat-
ing dynamic changes in transcription and DNA packaging.
Functional Category Analysis of Prominence-Specific
Expression
While trajectory clustering analysis highlights dynamic changes
in gene expression, this method is not well suited to visualizing
instances in which expression may be higher in one of the
prominences, but is not increasing or decreasing over the time
course. Therefore, to obtain a prominence-specific view of
expression changes we studied the set of 1,506 probe sets showing
at least one significant (2-fold) difference among prominences at a
given time point. This set was further divided into MdP (705
probes), MxP (495 probes), and FNP (760 probes) groups based
upon differences in expression from at least one other prominence
for the same time point.
These probe set groups were then analyzed with respect to GO,
InterPro, MGI Phenotype, and KEGG terms to determine over-
represented categories (Figure 7 and Tables S4A-E).
Consistent with the data presented in Figure 2, in which we
observed significant overlap of detectable expression among the
Figure 7. Selected categories showing increased expression in the facial prominences. Prominence-specific groups were created among
probes achieving limma statistical significance, with the additional criterion of a 2-fold change in gene expression, by assigning a probe to a group if
expression was increased in the group over at least one other prominence at a specific time point.
doi:10.1371/journal.pone.0008066.g007
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that the prominences had very similar gene expression dynamics
since many of the categories observed were seen in the MdP, MxP
and FNP. The data also supported our conclusions from the
trajectory clustering analysis that significant changes were
occurring in growth and differentiation. Alterations in RNA
expression levels of transcription factors, signaling molecules, cell
adhesion components, and structural proteins were apparent
(Figure 7). Cell fate determination, morphogenesis, motility,
migration, and adhesion were also prominent categories with
,30% of the up-regulated genes assigned to cell differentiation,
30% to cell communication, and 10% to cell motility in each of the
prominences. There were also notable prominence-specific
differences in the distribution of expressed genes within particular
categories that may help distinguish the ultimate fate of these
separate facial regions. In this regard, 36% of all genes increasing
by .2-fold within the MxP were associated with transcriptional
regulation, whereas this figure was 29% and 25% for the MdP and
FNP, respectively. Similarly, 16% of genes in the FNP were
categorized as cell adhesion, 13% in the MxP, and only 10% in the
MdP.
Progressive specialization of tissues in the prominences was
highlighted by the distribution of over-represented categories
associated with development of muscle, bone, cartilage, dentition,
vasculature, glands, epithelia, and the nervous system between the
MdP, MxP, and FNP (Figure 7). Among probes in the MdP-
specific group, the over-represented terms were associated with
signal transduction via MAPK and JNK second messenger
pathways, as well as with Hedgehog, VEGF, BMP, chemokine,
netrin, and neurotransmitter signaling. The MxP group was
enriched for terms associated with development of teeth, nerves,
and the endocrine system, correlating with formation of the
dentition, the trigeminal ganglion, and part of the pituitary system
from Rathke’s pouch in the oral epithelium. Also prominent in the
MxP were genes involved in Wnt signaling and transcriptional
control, particularly the negative regulation of transcription. The
FNP group was over-represented for categories associated with
fibroblast growth factor receptor signaling, sulfate assimilation, ion
transport, cell adhesion, cartilage formation, and nerve develop-
ment, some of which likely reflect development of the specialized
olfactory epithelium.
Over-represented categories shared between two of the three
prominence groups included muscle, neural crest cell, and
peripheral nervous system development in the MdP and MxP.
With respect to muscle development, 6.5% and 9.5% of genes
were assigned to this category in the MdP and MxP, respectively,
but only 2.5% in the FNP group. TGFb signaling, chemotaxis,
angiogenesis, the extracellular matrix, and skeletal formation were
highlighted in the MdP and FNP groups. In these two
prominences, 3% of genes were in the ECM organization and
biogenesis category, whereas the equivalent MxP dataset con-
tained less than 1% of such genes. The MxP and FNP groups
shared the categories of transcription factors, retinoic acid, cell
adhesion, and claudins. Overall, these findings reflect the
widespread importance of signal transduction, transcriptional
regulation, and cell:extracellular matrix contacts in growth and
morphogenesis of the developing face. With respect to pattern
formation, it was noticeable that gene categories associated with
different axes of polarity were highlighted in the three promi-
nences. The apparent segregation of radial (MdP), anterior/
posterior (MxP), and dorsal/ventral (FNP) patterning in these
prominences could represent one important developmental
mechanism whereby their individual identities are determined. A
further point of interest is that maternally imprinted genes were
clearly over-represented in the MdP compared with the MxP and
FNP (Figure 7 and Table S4E). Finally, as expected, many genes
we identified as expressed in our dataset were linked with the MGI
Phenotype categories ‘‘cleft palate’’, ‘‘midline facial cleft’’
‘‘abnormal cartilage morphology’’ and ‘‘abnormal myogenesis’’
(Table S4E).
Detailed Examination of Facial Prominence Expression by
Functional Category
The assignment of prominence expression changes to particular
GO, InterPro, KEGG or MGI Phenotype categories identified
some tissue-specific differences, but these were relatively limited
compared with the commonalities in cell metabolism, cell growth,
and differentiation. Therefore it was necessary to study gene
expression changes within a particular category, such as
transcription and cell adhesion, in greater detail to identify critical
prominence-specific differences. Accordingly, we examined indi-
vidual genes involved in cell cycle progression, general metabo-
lism, the cytoskeleton and cell adhesion, the extracellular matrix,
transcription, and chromatin dynamics. In each category, genes
were divided into those that were coordinately regulated in all
three prominences (level, increasing, or decreasing) and those that
were differentially regulated. With the exception of genes in the
‘‘level’’ group that were coordinately regulated, all the examples
presented were identified as differentially expressed by our
statistical analyses. Moreover, we concentrated on genes that
displayed at least a 2-fold expression difference between the first
and last time point. The exceptions, genes and probe sets that are
classified as increasing, decreasing, or prominence-specific, but
which failed to fulfill this additional 2-fold expression difference
criterion, are marked in Figures 8–19 with an asterisk.
Genes involved in Cell Cycle Progression and General
Metabolism
Analysis of genes involved in replication and cell division is
shown in Figure 8A–D. In agreement with the Gene Ontology
analysis there was an ,2-fold reduction in the transcript levels of
multiple genes involved in promoting cell cycle progression in all
prominences (Figure 8A). Such genes included many cyclins and
cyclin dependent kinases as well as genes required for nucleotide
metabolism, DNA replication, DNA repair, and cell division.
Concurrently, transcript levels for genes involved in the negative
regulation of cell cycle progression showed a tendency to increase
(Figure 8C). Transcripts encoding Rb1 (GeneID: 19645), the G2
checkpoint kinase Plk2 (GeneID: 20620), and several cyclin
dependent kinase inhibitors (cdki/cdkn), rose 2 to 4-fold in the
prominences. A general increase in expression was also noted for
the DNA damage response gene Gadd45b (GeneID: 17873), for
cdc42ep3 (GeneID: 260409), a negative regulator of cdc42,
(GeneID: 12540) and for Cdkn1c (GeneID: 12577), which encodes
p57 cdki. There were some modest prominence-specific differ-
ences in Cdkn1c expression, though, with the FNP displaying ,2-
fold lower transcript levels at E10.5 and the MdP having 3 to
4-fold higher levels by E12.5. Nevertheless, the overall similarity of
the expression profiles for multiple cell cycle associated genes in
the three prominences is striking and suggests coordinate
regulation. We note that there was a small subset of such genes
that displayed prominence-specific gene expression (Figure 8D). In
the FNP, transcripts for DDit4l (GeneID: 73284), Pla2g16
(GeneID: 225845), Rprm (GeneID: 67874), Gadd45a (GeneID:
13197), and Gadd45g (GeneID: 23882) were found at 2 to 4-fold
higher levels than in the other prominences. Moreover, expression
of Pmaip1 (GeneID: 58801), a gene involved in the induction of
Orofacial Gene Expression
PLoS ONE | www.plosone.org 10 December 2009 | Volume 4 | Issue 12 | e8066Figure 8. Expression profiles of cell cycle regulatory genes. Each panel shows the expression profile for the gene or genes indicated. The x-
axis represents the five time points for each prominence (MdP, MxP, and FNP). The y-axis shows the relative expression level on a log2 scale – i.e.
every integer represents a doubling in the level of expression from the preceding number. The dashed black line indicates the average expression
level for all probes. The lines of other colors illustrate the data obtained for the indicated gene shown in the key at the right. If only one gene is
shown in a panel the various colors indicate the data obtained from different probes corresponding to that gene. Genes marked by an asterisk in the
increasing, decreasing, or prominence-specific categories have statistically significant differences in expression over the time course or between
prominences but fail to satisfy the additional criterion of a 2-fold change in gene expression.
doi:10.1371/journal.pone.0008066.g008
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doi:10.1371/journal.pone.0008066.g009
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MdP and remained relatively constant throughout the analysis,
whereas in the MxP and FNP the Pmaip1 expression profiles were
more dynamic, peaking and then decreasing.
Concurrent with decreased expression of genes involved with
replication, we also observed ,2-fold reductions in the expression
of multiple genes associated with basic cellular processes, including
nuclear import/export, transcription, RNA processing, and RNA
degradation, in all three prominences between E10.5 and E12.5
(Figure 9A). Similar transcript reductions were observed for several
genes required for ribosome biogenesis, protein synthesis, protein
folding, protein degradation, and aspects of mitochondrial
function (Figure 9A). Transcripts for many other genes involved
in these basic processes remain essentially level during this
developmental period (Figure 9B). Only a few genes displayed a
slight increase in transcript levels, including several involved in
ubiquitination, as well as the catabolism of nucleotides, fatty acids
and cholesterol (Figure 9C). There was also an MdP-specific
increase in transcript levels for enzymes associated with skeletal
muscle function, including Car3 (GeneID: 12350) and Gatm
(GeneID: 67092) (Figure 9D), reflecting the development of the
tongue and masticatory muscles from this prominence [29]. Taken
together, though, these observations indicate that there is a
simultaneous overall reduction in the rate of growth and in many
aspects of metabolism in all three facial prominences from
E10.5–E12.5.
Figure 10. Expression profiles of keratin genes. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g010
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We next examined whether expression of genes involved in
differentiation were activated to counter-balance the decreased
expression of those associated with replication. Several classes of
genes were chosen to study the process of differentiation, including
intermediate filament proteins (Figure 10), extracellular matrix
molecules (Figures 11–14), cell adhesion molecules (Figures 15,
16), and transcription factors (Figures 17, 18). As described in
detail below, these studies demonstrated that the three sets of
prominences exhibited striking commonalities in the onset and
progression of differentiation. We focused initially on keratin genes
(Figure 10A, B) because their expression provides an excellent
readout of development of the surface ectoderm from a simple to
multilayered epithelium [30]. Over the time course, there was a 3
to 4-fold reduction in Krt8 (GeneID: 16691) and Krt18 (GeneID:
16668) transcripts, which are associated with simple embryonic
epithelia, and the levels of Krt7 (GeneID: 110310) and Krt19
(GeneID: 16669) transcripts also dropped initially before recover-
ing (Figure 10A). Concurrently, there was a rise in the transcript
levels for keratins associated with more mature stratified epithelia
(Figure 10B). Transcripts derived from Krt5 (GeneID: 110308),
Krt14 (GeneID: 16664), and Krt15 (GeneID: 16665), which are
expressed in the basal epithelial layers, rose exponentially from
E10.5 onwards. Krt1 (GeneID: 16678) and Krt10 (GeneID: 16661)
transcripts, associated with the suprabasal epidermal layers, were
increasing more slowly during the same period. Lastly, Krt6a
(GeneID: 16687) and Krt17 (GeneID: 16667), which are expressed
in the suprabasal layers of epithelia of the oral cavity, including the
tongue [30], began to rise at the later time points.
The switch from keratin genes expressed in simple epithelia to
those present in stratified epithelia occurred simultaneously in the
three prominences. Nevertheless, evident differences in the three
Figure 11. Expression profiles of collagen genes. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g011
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(Figure 10A, B). In the FNP the switch between keratins associated
with simple (Krt8 and Krt18) versus complex (Krt15) epithelia
progressed at a much slower rate. The MxP also displayed
differences from the other prominences, especially in the levels of
Krt5 and Krt14 expression, which were higher, and the expression
profiles of Krt6a and Krt7, which were less dynamic. MdP specific
differences were less pronounced. Overall, though, each promi-
nence exhibited a unique molecular fingerprint of keratin gene
expression. These prominence-specific differences were also
reflected in the expression of Trp63 (GeneID: 22061), encoding
the p63 transcription factor that promotes the commitment to
epithelial stratification [31]. Transcripts encoding p63 were lowest
in the FNP reflecting the slower rate of change between keratins
characteristic of simple versus stratified epithelia in this promi-
nence (Figure 10C).
Genes Encoding Components of the Extracellular Matrix
Collagens and the Collagen Processing Machinery. Tran-
scripts encoding many components of a differentiated extracellular
matrix were rapidly increasing during the same period in all
prominences, typified by many collagen gene family members
[32,33]. Though expression of a small number of collagen genes
decreasedovertime,orremainedlevel(Figure 11A,B),a majorityof
these genes displayed co-ordinate up-regulation of transcript levels
in the three prominences (Figure 11C and Figure S4). Several of
these genes, including Col1a2 (GeneID: 12843), Col3a1 (GeneID:
12825), and Col5a2 (GeneID: 12832), encoding fibril-forming
collagens, already had high transcript levels in all prominences by
E10.5, and their expression continued to increase by up to 6-fold by
E12.5. Another set of collagen genes had lower expression at the
outset of the time course, but then transcript levels rose coordinately
through E12.5 in the MdP, MxP, and FNP. These genes include
those encoding fibril-forming collagens (Col1a1, GeneID: 12842;
Col5a1,GeneID: 12831; Col27a1,GeneID: 373864),fibril associated
collagen (Col16a1, GeneID: 107581), and structural ‘‘beaded
filament’’ collagens (Col6a 1, GeneID: 12833; Col6a2, GeneID:
12834; Col6a3, GeneID: 12835). This increase was most dramatic
for the membrane associated collagen Col17a1 (GeneID: 12821), for
which levels rose .30-fold between E10.5–E12.5. The rapid
increase in transcript levels for this type XVII collagen is
presumably indicative of desmosome formation associated with
the development of the stratified epithelia of the skin and oral cavity
[32,33].
A subset of collagen genes, particularly Col4a1 (GeneID: 12826)
and Col4a2 (GeneID: 12827), encoding fibril-forming collagens,
were expressed at high but generally flat levels in all prominences
throughout this period of orofacial development (Figure 11B).
Only two collagens, Col2a1 (GeneID: 12824) and Col18a1
(GeneID: 12822), showed a downward trend of expression in all
prominences (Figure 11A). Col2a1 transcript levels started high and
then dropped up to 4-fold during this developmental period,
although this reduction was less pronounced in the FNP. This
observation reflects down-regulation of Col2a1 during the
transition from chondrocyte precursors to differentiated cells.
Collagen type XVIII is a component of some basement
membranes, but also generates the peptide endostatin that inhibits
endothelial proliferation [32,33]. A reduction in Col18a1 expres-
Figure 12. Expression profiles of genes encoding collagen processing enzymes and chaperones. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g012
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doi:10.1371/journal.pone.0008066.g013
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angiogenesis in the prominences.
Although there was considerable evident coordinate regulation
of collagen gene expression, there were also clear prominence-
specific differences (Figure 11D). The FNP was distinguished by
increasing Col9a1 (GeneID: 12839) transcript levels, compared
with decreasing levels in the MdP and MxP. The FNP also had the
highest Col9a3 (GeneID: 12841) transcripts levels by E12.5, with
intermediate levels seen in the MdP and low levels in the MxP.
Distinctive expression profiles in each prominence were also
observed for Col8a2 (GeneID: 329941), and Col23a1 (GeneID:
237759) (Figure 11D). In the MxP, Col9a2 (GeneID: 12840)
transcript levels remained relatively flat throughout the time
course, whilst this gene showed increasing levels in the other
prominences (Figure 11D). For the MdP, there was a slight
increase in Col13a1 (GeneID: 12817) levels, whereas they
decreased ,3-fold in the MxP and FNP (Figure 11D). The
significant prominence-specific differences in expression apparent
for this group of collagen genes, coupled with more subtle
expression differences for Col4a5 (GeneID: 12830), Col6a1, Col8a1
(GeneID: 12837), Col11a1 (GeneID: 12814), Col12a1 (GeneID:
12816), and Col14a1 (GeneID: 12818) (Figure 11C), will likely
generate a specific extracellular matrix in each facial prominence.
The production of mature collagen proteins also requires several
processing enzymes and specific chaperones [32,33]. We observed
high but relatively constant expression levels for several genes
necessaryforcollagen modification and assembly(Figure 12A; P4hb,
GeneID: 18453; Serpinh1, GeneID: 12406), while expression of
others increased 2 to 8-fold (Figure 12B; Bmp1, GeneID: 12153; Lox,
GeneID: 16948; Loxl2, GeneID: 94392; Plod2, GeneID: 26432) in
concert with collagen gene expression. Limited prominence-specific
expression was apparent for Loxl1 (GeneID: 16949), Tll1 (GeneID:
21892), and Pcolce2 (GeneID: 76477) (Figure 12C). Thus, in each
prominence there will be a unique combination of collagens,
collagen chaperones and processing enzymes that together will
generate specific extracellular matrix environments.
Other ECM Components. A small number of genes
encoding other structural proteins associated with the
extracellular matrix were down-regulated in all prominences
including alpha 1 laminin (Lama1, GeneID: 16772), Smoc1
(GeneID: 64075), and Matn3 (GeneID: 17182) (Figure 13A), or
else displayed relatively level expression profiles (Figure 13B).
However, many other genes encoding components of the nascent
skeleton and extracellular matrix showed significant and
coordinate expression increases in all prominences from E10.5–
E12.5 (Figure 13C). Expression levels of genes encoding several
laminins as well as other proteins involved in microfibril formation
Figure 14. Expression profiles of genes encoding extracellular matrix modifying components. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g014
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proteoglycans, including decorin (Dcn, GeneID: 13179), biglycan
(Bgn, GeneID: 12111), asporin (Aspn, GeneID: 66695), and
osteoglycin (Ogn, GeneID: 18295), were also increasing up to 30-
fold during this period. We note that some genes such as Spon1
(GeneID: 233744) (Figure 13C) and Emilin2 (GeneID: 246707)
(Figure S5) exhibited more complex expression profiles, but were
still coordinately regulated.
The coordinate regulation of genes encoding various ECM
components was nevertheless associated with prominence-specific
differences in the rate or degree of change over the time course of
our analysis. Such differences are likely to yield some prominence-
specific variation in extracellular matrix composition. More
profound differences may originate from a subset of genes that
displayed more distinctive prominence-specific expression patterns
(Figures 13D). The MdP was distinguished by a dramatic increase
in the expression levels of Thbs4 (GeneID: 21828) compared with
the other prominences, but relatively flat expression of Sdc2
(GeneID: 15529). In the FNP, expression levels for Tnn (GeneID:
329278) remained stable whereas expression of this gene was
changing in the MdP and MxP. In contrast, expression of Acan
(GeneID: 11595), Reln (GeneID: 19699), and Matn4 (GeneID:
17183), increased more in the FNP than in the other two
prominences. Of note, Matn4 expression rose ,60-fold in the FNP
over the time course of the analysis, compared with a 4-fold rise in
the MxP. Lad1 (GeneID: 16763) and Hapln1 (GeneID: 12950) also
showed FNP specific gene expression profiles.
In parallel with changes in expression of genes encoding
structural components of the ECM, there were corresponding
changes in transcript levels for those encoding modifying enzymes
and inhibitors (Figure 14A–C). We did not observe decreases in
the expression of such genes, and only a small subset displayed
relatively constant transcript levels (Figure 14A). Instead, a
majority of these genes including Sulf1 (GeneID: 240725),
Mmp11 (GeneID: 17385), Timp3 (GeneID: 21859), Adam22
(GeneID: 11496), Adamts20 (GeneID: 223838), and Adamtsl1
(GeneID: 77739) showed a coordinate increase in expression in
the three prominences (Figure 14B). Nevertheless, a number of
genes had prominence-specific expression patterns, particularly
Fap with a unique expression profile in each prominence
Figure 15. Expression profiles of genes encoding junctional complex proteins. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g015
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and Adamts15 (GeneID: 235130) transcripts, as well as lower levels
of Has2 (GeneID: 15117) expression, distinguished the MdP from
the MxP and FNP. The FNP itself had a different pattern of Timp1
(GeneID: 21857), Hs6st2 (GeneID: 50786), Htra1 (GeneID:
56213), Mmp2 (GeneID: 17390), and Papss2 (GeneID: 23972)
expression from the other two prominences. Overall, for all aspects
of the ECM and its processing enzymes, the MxP showed fewer
unique expression profiles than the MdP and FNP. Instead, it
tended to have an intermediate profile, sharing some expression
profiles with the FNP and others with the MdP.
Genes Encoding Cell:Cell Communication and Cell
Adhesion Molecules
The Gene Ontology and InterPro analyses shown in Figures 6
and 7 and Tables S3 and S4 highlighted gene categories associated
with cell:cell adhesion as increasing in all prominences, and also
suggested that claudin family members were differentially
expressed in the FNP. Examination of individual genes associated
with gap junctions, tight junctions, and desmosomes confirmed
these dynamic and tissue-specific expression changes (Figure 15A–
D). Genes encoding catenin proteins, which link the cytoskeleton
with adherens junctions [34], showed coordinate decreasing
(Ctnnal1, GeneID: 54366; Fig 15A), level (Ctnna1, GeneID:
12385; Ctnnb1, GeneID: 12387; and Ctnnd1, GeneID: 12388:
Fig 15B), or increasing (Ctnna2, GeneID: 12386; Fig. 15C)
expression profiles in the three prominences. Similarly, expression
of the gap junction protein gene Gjb3 (GeneID: 14620, connexin
31) was decreasing in all prominences, while there was a
concomitant rise in Gjb2 (GeneID: 14619, connexin 26) and
Gjb6 (GeneID: 14623, connexin 30) expression. Genes encoding
desmosomal proteins, including Dsc2 (GeneID: 13506), Dsp
Figure 16. Expression profiles of genes encoding cell adhesion molecules. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g016
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PLoS ONE | www.plosone.org 19 December 2009 | Volume 4 | Issue 12 | e8066Figure 17. Expression profiles of genes encoding transcription factors with coordinately regulated (A–C) or complex (D) patterns.
Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g017
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PLoS ONE | www.plosone.org 20 December 2009 | Volume 4 | Issue 12 | e8066Figure 18. Expression profiles of genes encoding transcription factors with coordinate regulation in two of the three prominences.
Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g018
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in expression within in the MdP, MxP, and FNP between E10.5
and E12.5. These findings reflect increased adhesion, cell
communication, and differentiation within epithelial sheets shared
by the three facial prominences. Several genes associated with
tight junctions, including Tjp1 (GeneID: 21872), Tjp2 (GeneID:
21873), and Tjp3 (GeneID: 27375), had slightly decreasing or
essentially level expression in the facial prominences. In contrast,
the expression profiles for many other genes encoding adherens
and tight junction proteins [35,36] displayed markedly different
dynamics in the FNP from the other two prominences
(Figure 15D). With respect to adherens junctions, Pkp2 (GeneID:
67451), Ssx2ip (GeneID: 99167) and Shroom3 (GeneID: 27428) all
showed higher expression in the FNP, as did the tight junction
genes Cgn (GeneID: 70737) and Ocln (GeneID: 18260). Higher
expression of the tight junction gene Cldn1 (GeneID: 12737) was
characteristic of the MdP and MxP, whereas Cldn3 (GeneID:
12739), Cldn6 (GeneID: 54419), Cldn7 (GeneID: 53624), Cldn9
(GeneID: 56863) were expressed at greater levels in the FNP
throughout this developmental window. Cldn11 (GeneID: 18417)
and Cldn23 (GeneID: 71908) expression also rose more rapidly in
the FNP than in the other two prominences. Overall, these
findings support a different composition and/or function of the
junctional complexes in the FNP compared with the MdP and
MxP. In this context, the regulatory molecule protein kinase C
zeta (Prkcz, GeneID: 18762), which associates with tight junctions
[35,36], is also expressed at a higher level in the FNP. The MdP
had higher levels of Amot (GeneID: 27494) expression, presumably
associated with accelerated vasculature development in this
prominence, as well as the cell:matrix adherens junction gene
Nexn (GeneID: 68810).
The dynamic changes in the expression of genes encoding
cell:cell junction components prompted a more detailed exami-
nation of genes involved in intercellular communication and cell
adhesion (Figure 16A–D). A subset of these genes was coordinately
down-regulated as development progressed (Figure 16A), espe-
cially Igdcc3 (previously known as Punc, GeneID: 19289) whose
expression decreased by 15 to 30-fold during our analysis. In
agreement with our findings, previous reports showed that Igdcc3,
which encodes a neural cell adhesion molecule, has widespread
expression in the mesenchyme of the facial prominences at E10.5,
but soon after becomes limited to discrete regions of the CNS
[37,38]. Several other genes had relatively stable expression levels
(Figure 16B), including Pvrl1 (GeneID: 58235), a gene that when
mutated results in human CL/P [39,40,41]. However, consistent
with the onset of differentiation, a majority of expression profiles
were coordinately up-regulated in the facial prominences,
including genes that encode specific cell adhesion molecules,
cadherins, and protocadherins, which exhibited 2 to 10-fold
increases (Figure 16C).
Prominence specific expression profiles were observed for
several additional genes involved in cell adhesion (Figure 16D).
In particular, in the MdP expression of Cdh15 (GeneID: 12555), a
gene associated with muscle differentiation [42], showed a sharp
increase compared to the other prominences. Relatively low,
stable, levels of Pcdh8 (GeneID: 18530) and Pcdh19 (GeneID:
279653) transcripts were also characteristic of the MdP. Distinctive
expression profiles were not observed for the MxP, a finding in
common with the data obtained from extracellular matrix gene
analysis (see above). However, transcript levels for Itga8 (GeneID:
241226) and Itgb5 (GeneID: 16419) were slightly higher in the
MxP compared to the other prominences. Several genes showed
higher basal expression levels in the FNP, including those
encoding the cell adhesion molecules Pcdh20 (GeneID: 219257),
Pcdh21 (GeneID: 170677), Cadm1 (GeneID: 54725), and Epcam
(GeneID: 17075). In this context, Pcdh21 is associated with
Figure 19. Expression profiles of genes encoding chromatin binding and remodeling factors. Legend as in Figure 8.
doi:10.1371/journal.pone.0008066.g019
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between the FNP and the two other prominences reflect the
specialized function of the olfactory epithelium.
Transcription Factors
Although we observed significant changes in the expression of
genes involved in cell cycle, cell adhesion, cell structure, and the
extracellular matrix, by far the most dramatic molecular signatures
of the prominences were provided by genes encoding sequence-
specific DNA binding transcription factors (Figures 17A–D, 18A–
C). Multiple transcription factors displayed coordinated gene
expression in the three prominences over the time course of this
analysis (Figure 17A–C and Figure S6). A small number of genes
were down-regulated (Figures 8A and 17A) including those
encoding p53 (GeneID: 22059), E2F5 (GeneID: 13559), and Sp6
(GeneID: 83395) whose expression dropped 2 to 4-fold correlating
with the reduction in cell proliferation and general cellular
metabolism noted above. Transcription factors implicated in
maintenance of stem cell function, including Sall4 (GeneID:
99377) and Zbtb16 (Plzf, GeneID: 235320) [44,45,46], or in the
expansion of precursor populations, such as Arid3b (GeneID:
56380) [47], were also down-regulated ,5-fold. Several genes
were expressed at relatively stable levels in the three prominences,
including members of the Stat and Smad transcription factor
families and Cited2 (GeneID: 17684), which encodes a transcrip-
tional modulator (Figure 17B). The expression of a much larger
group of genes was up-regulated in all prominences (Figure 17C).
This class of genes includes Fosl2 (GeneID: 14284), Runx2
(GeneID: 12393), and Sp7 (osterix, GeneID: 170574), which are
required for development of skeletal elements [48,49,50], and
whose transcript levels rose 5 to 15-fold during this developmental
window. Similarly, expression of Klf4 (GeneID: 16600), a gene
responsible for skin barrier function in the differentiating
epidermis [51], was increased ,4 to 8-fold in all three
prominences. Irf6 (GeneID: 54139), a gene expressed in facial
ectoderm and critical for patterning mouse orofacial development
as well as mutated in human CL/P [52,53,54], was also present in
this category. Several genes that encode components of signal
transduction pathways in many cell types, including Stat3
(GeneID: 20848), and the nuclear hormone receptors, corepres-
sors, and coactivators Ncoa1 (GeneID: 17977), Ncor2 (GeneID:
20602), Nr3c1 (GeneID: 14815) and Thra (GeneID: 21833), were
also coordinately up-regulated. In addition, all members of the
NFI transcription factor gene family demonstrated coordinate 10
to 50-fold increases in expression over this time period in the facial
prominences. A further group of transcription factor genes
displayed distinctive patterns of expression in each of the three
prominences that did not fall into the simple categories noted
above (Figure 17D). This group was quite small and included
genes such as Sox8 (GeneID: 20681) and Irx4 (GeneID: 50916),
which had transcript levels rising and falling in different
prominences. Another example was Foxg1 (GeneID: 15228), with
stable expression in each prominence, but with a low, interme-
diate, and high level of expression in the MdP, MxP and FNP
respectively.
The microarray data were also processed to ascertain those
transcription factor genes that exhibited prominence-specific
expression or were coordinately regulated in any two of the three
prominences (Figure 18, and Figures S7 and S8). This analysis
revealed a complex series of expression profiles for each
prominence, with the MdP and FNP showing the greatest
differences. With respect to the MdP, our analysis showed that
several genes required for muscle differentiation [29] including
Tcf21 (capsulin, GeneID: 21412), Myf5 (GeneID: 17877), Myod1
(GeneID: 17927), Myog (GeneID: 17928) and Msc (GeneID:
17681), were expressed at higher levels in this prominence
(Figure 18A). Expression of Tcf21 was essentially level throughout
the time course, with levels 2 to 3-fold higher than in the MxP and
FNP. Expression of the other genes increased between 4 to 30-fold
between E10.5–E12.5, presumably reflecting development of the
tongue and the muscles of mastication [55]. Additional genes more
highly expressed in the MdP included Dlx5, Dlx6, Gsc, Hand1
(GeneID: 15110), and Hand2, consistent with their developmental
roles in patterning the mandible [24,26].
The MxP shared multiple expression profiles with either the
MdP or FNP, and only a few genes showed expression differences
specific to this prominence – and most of these were subtle
(Figure 18B). Thus, Foxc2 (GeneID: 14234) and Pknox2 (GeneID:
208076) showed a slight decrease in expression in the MxP
compared with the other prominences, whereas levels of Foxl2
(GeneID: 26927), Irx3 (GeneID: 16373) and Irx5 (GeneID: 54352)
were slightly higher. The FNP displayed higher expression for
genes encoding transcription factors involved in specification and
development of ectodermal placodes and in neurogenesis [56,57],
including Pax6 (GeneID: 18508), Sox2 (GeneID: 20674), Ascl1
(GeneID: 17172), Olig1 (GeneID: 50914) and Olig2 (GeneID:
50913) (Figure 18C). This observation again presumably reflects
the development of the olfactory placodes and specialized olfactory
epithelium in the FNP. Transcripts of genes involved in patterning
the FNP, such as Pax7 (GeneID: 18509), were also expressed at a
higher level in this prominence (Figures 17D). The integration of
the multiple differences in transcription factor gene expression
profiles is likely to provide a powerful driving force for
discriminating the different prominences during development.
Genes Associated with Chromatin Dynamics
We also examined genes associated with chromatin structure
(Figure 19A–D) since alterations in DNA packaging would be
expected to accompany the rapidly changing profiles of transcrip-
tion factors, as well as the switch between genes required for cell
cycle progression versus differentiation. As indicated by the
trajectory clustering analysis (Table S2), we observed dynamic
changes in expression of genes associated with chromatin
remodeling, DNA methylation, and gene regulation. Our findings
imply that there is a switch from a progenitor to a differentiated
cell program of gene accessibility during the period under analysis
in all prominences. Thus, expression of genes encoding particular
members of the Chd family of chromatin remodeling proteins was
decreasing (Chd1, GeneID: 12648; Chd7 GeneID: 320790;
Figure 19A), while others remained relatively constant (Chd8,
GeneID: 67772; Figure 19B), and at least one was increasing
(Chd9, GeneID: 109151; Figure 19C). These findings may reflect
the difference between maintaining chromatin assembly functions
and epigenetic marks during DNA replication versus the
established role of Chd9 in regulating genes required for skeletal
tissue development [58]. An alteration in chromatin dynamics was
also indicated by the increasing expression of genes encoding
many components of the SWI/SNF remodeling complex,
including Smarca1 (GeneID: 93761), Smarca2 (GeneID: 67155),
Smarcc2 (GeneID: 68094) and Smarcd3 (GeneID: 66993)
(Figure 19C), whereas others such as Smarcc1 (GeneID: 20588)
and Smarce1 (GeneID: 57376) showed relatively constant expres-
sion levels (Figure 19B). The majority of these chromatin
remodeling genes showed coordinate regulation of expression,
with the exception of Baz1a (GeneID: 217578), which was
preferentially down-regulated in the MdP (Figure 19D). There
was also a general increase in transcripts for genes involved in
histone acetylation, including Kat2b (Pcaf, GeneID: 18519) and
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chromatin accessibility. Simultaneously, expression of genes
encoding specific components of the histone deacetylase and
methyltransferase machinery declined over this developmental
window, including Sap18 (GeneID: 20220), Sap30 (GeneID:
60406), and Suv39h2 (GeneID: 64707). Interestingly, though,
transcripts for the HDAC components Hdac5 (GeneID: 15184)
and Chd3 (GeneID: 216848) were rising. There was also a 2-fold
increase in transcripts for the deacetylase Phf21a (GeneID:
192285), which may reflect the importance of this gene in the
repression of neural genes in non-neural tissues [59].
With respect to polycomb group and trithorax genes, expression
of Asxl3 (GeneID: 211961), Cbx4 (GeneID: 12418), Cbx6 (GeneID:
494448) and Mll5 (GeneID: 69188) increased during orofacial
development (Figure 19C). These genes encode the archetypal
epigenetic marker proteins responsible for repression of inappro-
priate genes in differentiated cells [60]. In contrast, transcripts
corresponding to Pcgf6 (GeneID: 71041), Cbx1 (GeneID: 12412),
and Cbx2 (GeneID: 12416) decreased between E10.5–E12.5 in the
facial prominences. These data imply that such polycomb proteins
could be responsible for maintaining progenitor cells by repression
of genes required for commitment to differentiation. Dnmt3b
(GeneID: 13436), encoding an enzyme involved in de novo CpG
DNA methylation, which is associated with transcriptional
repression and heterochromatin formation [61], was also down-
regulated between E10.5–E12.5 (Figure 19A). In contrast, Dnmt3a
(GeneID: 13435) showed flat or increasing expression depending
on the probe used (data not shown). The timing of the switch
between these related DNA methylases, also observed in embryos
at the protein level [62], potentially indicates that they have
different roles in early progenitor versus differentiated cells. The
dynamics of Dnmt3b expression are also of interest given its
mutation in human immunodeficiency-centromeric instability-
facial anomalies (IFC) syndrome (OMIM: 242860) [61]. Taken
together, the changes in the expression of genes involved in DNA
modification and chromatin structure demonstrate that the
genome is undergoing rapid and dynamic changes that will
greatly alter transcription factor accessibility.
Analysis of Novel Facial Gene Expression
Our studies highlighted a large number of genes not previously
associated with the developing face. This group of genes included
well-studied genes as well as novel genes for which little or no
functional information exists. We selected a number of these genes
for further analysis based, in part, upon their high levels of
expression in discrete prominences as determined by the
microarray analysis (Figure S9). RNA in situ probes were designed
for each gene and WMISH was employed to determine the
location of expression within each prominence between E10.5–
E12.5. The spatial distribution of transcripts observed using
WMISH displayed excellent agreement with the microarray
expression results, providing additional verification of our dataset
(Figures 20, 21, and Figure S9). Figure 20A–D shows the WMISH
data obtained for cDNA 2610017I09Rik (GeneID: 66297), a
transcript of unknown function [63], that was readily detected by
microarray analysis in each prominence at all time points studied.
WMISH confirmed that this gene was expressed highly in all three
prominences, but also indicated that the distribution was not
uniform. Expression of 261007I09Rik showed a proximal distri-
bution in the MdP and MxP, whereas in the FNP it was more
concentrated in the medial rather than lateral nasal prominences.
2610017I09Rik maps to mouse chromosome 1, in close vicinity to
Pou3f3 (GeneID: 18993) (Figure S10), with which it shares a similar
expression profile in the facial prominences and CNS.
The additional transcripts highlighted in Figure 20 show
preferential expression in the FNP over the other prominences,
in agreement with the microarray data. One of these, correspond-
ing to the cDNA 9430073N08Rik (GeneID: 77296), was expressed
in a portion of both the lateral and medial components of the nasal
prominence proximal to the oral cavity (Figure 20E, F). This latter
gene, Fam162b, is predicted to encode an integral membrane
protein, but little else is know about its function [63]. For the rest
of the genes that display FNP-specific expression, we utilized the
distribution of Elavl4 (Hud) transcripts as a landmark ([27];
Figure 20G). Expression of Elavl4 was elevated in the FNP and
localized to the developing olfactory epithelium of the nasal pit
consistent with its association with neurogenesis. The other FNP-
enriched transcripts analyzed (Prr15, GeneID: 78004; Fam107a,
GeneID: 268709; Wscd1, GeneID: 216881; and Image:6309403,
GenBank gi: 21854763) were similarly localized in the nasal pit
(Figure 20H–R), presumably reflecting a role for these genes in
olfactory neurogenesis. Expression of Prr15 (also termed G90),
which may encode a proline-rich protein or act as a non-coding
RNA, has previously been observed in post-mitotic cells, including
within the olfactory epithelium ([64]; Figure 20H, I). Fam107a
(Figure 20J–L) (also known as BC055107, DRR1 and TU3A) may
encode a nuclear protein linked to growth control and tumori-
genesis [65,66]. Wscd1 (Figure 20, M–P) is a wsc domain-
containing protein predicted to be integral to the cell membrane
[63]. The Image:6309403 transcript (Figure 20Q, R) is predicted to
encode microRNA 429 (mir429, GeneID: 723865) of unknown
function [63].
WMISH was also used to examine genes that showed high
expression in the MdP and/or MxP in the microarray analysis,
and once again we observed good agreement between the data
obtained using the two methods (Figure 21 and Figure S9). Ifitm3
(GeneID: 66141), Lrba (GeneID: 80877), and AI606473 (GeneID:
99686) were expressed in both the MdP and MxP, although with
clearly different spatiotemporal distribution patterns. Ifitm3
(interferon induced transmembrane protein 3) [67] was expressed
primarily in the ectoderm of the cleft between the MdP and MxP
(Figure 21A, B). Lrba, which encodes an LPS-responsive beige-like
anchor protein that may be involved in vesicle trafficking and
Notch regulation [68], was expressed more diffusely in the MdP
and MxP as well as in the more caudal branchial arches
(Figure 21C–E). Expression of AI606473, a gene of unknown
function [63], occurred primarily in the MxP and the distal
portion of the MdP, although a discrete domain of expression was
also seen in the medial nasal prominences (Figure 21F, G). This
expression pattern showed strong similarity with that of Lhx8 ([25];
Figure S9). AI606473 is located just upstream of Lhx8 on mouse
chromosome 3 and is transcribed in the opposite direction (Figure
S10), suggesting that these two genes may share common cis-
regulatory elements and/or a bidirectional promoter.
Other genes analyzed displayed more prominence-specific gene
expression patterns. A930038C07Rik (GeneID: 68169) showed the
highest levels of expression in the MxP, particularly between E11–
E12, and serves as a valuable new marker for this prominence
(Figure 21, H–K). This gene, known as C4orf31 (GeneID: 79625)
in human, encodes a hypothetical membrane protein and is
negatively regulated by Hox genes in the developing kidney [69].
This latter observation is intriguing given that the anterior-
posterior Hox code terminates just caudal to the MxP [70].
Specific expression in the MdP was seen for two genes linked with
G protein coupled signaling [71,72], Gpr50 (GeneID: 14765)
(Figure 21, L–N) and Rgs5 (GeneID: 19737) (Figure 21, O–Q).
Expression of Gpr50 was concentrated in the rostral MdP, whereas
Rgs5 was expressed more distally. At E10.5, both genes were
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from E11.5 onwards. Expression of Gpr50, a melatonin-related
orphan receptor, was also associated with Rathke’s pouch in the
roof of the oral cavity, suggesting a role in the development of the
pituitary gland. AV026068 (GeneID: 102265), termed NBLA00301
in human (GeneID: 79804), encodes a short hypothetical protein
of unknown function [63], and its transcripts were expressed at
elevated levels in the MdP throughout the developmental time
course (Figure 21, R–T). The expression domain of AV026068 in
the distal MdP, as well as in the posterior region of the limb bud,
resembled that of the aforementioned Hand2 gene (Figure 4).
AV026068 is positioned adjacent to Hand2 on mouse chromosome
8, but is expressed from the opposite strand beginning several kb
upstream of the latter’s transcriptional start site (Figure S10). This
arrangement is remarkably similar to those described above for
2610017I09Rik and Pou3f3 as well as Lhx8 and AI606473. Again,
the similarity between the expression patterns of AV026068 and
Hand2, as well as the bidirectional nature of these two gene’s
transcription units, suggests that they share common mandible-
specific cis-regulatory sequences. The finding that this arrange-
ment occurs for these three new pairs of genes indicates that it may
be a common mechanism of coordinating gene expression in the
developing mouse face.
Discussion
The development of the vertebrate face is an intricate process
that requires the coordinate growth, morphogenesis, and fusion of
separate prominences [2,3,4]. Although the face eventually forms
an integrated structure, the paired mouse facial prominences – the
Figure 20. Expression of representative genes in the facial prominences I: global and FNP-specific genes. Whole mount in situ
expression analysis of: 2610017I09Rik (A–D); 9430073N08Rik, Fam162b (E, F); Elav14 [HuD] (G); Prr15 (H, I); Fam107a (J–L); Wscd1 (M–P); and Image
6309403 (Q, R) showing lateral (A, D, E, G, H, J, M, P, Q) or ventral (B, C, F, I, K, L, N, O, R) views of E10.5 (A, B, E–K, M, N, Q, R) or E11.5 (C, D, L, O, P) mice.
Note for panel G that despite the clear expression of Elavl4 in the trigeminal ganglia, we did not detect expression in the MxP and MdP RNA samples
we had purified for microarray analysis. This finding provides additional proof that the samples we have purified were not significantly contaminated
with surrounding tissue. Abbreviations: drg, dorsal root ganglia; e, eye; fn, frontonasal prominence; h, hyoid arch; l, lateral nasal prominence; m,
medial nasal prominence; md, mandibular prominence; ov, otic vesicle; p, nasal pit; t, telencephalon; tg, trigeminal ganglion; x, maxillary prominence.
doi:10.1371/journal.pone.0008066.g020
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functional components of the skeleton, the sensory system, and the
respiratory and digestive systems. Variations in the growth
properties and derivatives of these prominences have been a
major factor driving vertebrate evolution and the expansion of
vertebrate species into disparate ecological niches. Furthermore,
aberrant development of these prominences is a major factor in
human orofacial clefting and other craniofacial birth defects.
Although previous studies have identified many individual genes
and pathways required for facial development, we still lack a clear
understanding of the gene networks regulating face formation [2].
Here we have utilized a systems biology approach to document the
panoply of genes expressed during a critical period of mouse
orofacial development. The genome-wide analysis of transcripts
present in the individual facial prominences yields a comprehen-
sive overview of the similarities and differences in gene expression
among the three facial prominences at five time points over a two
day developmental window. We have confirmed individual aspects
of our microarray expression dataset by comparing our results
with known expression patterns of representative genes, as well as
by WMISH studies of selected novel orofacial transcripts. This
provides a robust and powerful dataset with low variance due to a
combination of stringent experimental protocols and multiple
biological replicates and its statistical strengths make possible
sophisticated bioinformatic analyses and network predictions
[55,73]. On a more basic level, the dataset may help uncover
individual genes or groups of genes that have previously been
overlooked as components of the repertoire required for face
formation or which can be reactivated in head and neck cancer.
A central component of our present analysis has been to identify
stage- and tissue-specific gene signatures associated with the
developing facial prominences. We determined that the facial
tissue we analyzed contained .20,000 expressed transcripts, many
of which were coordinately regulated in the three prominences.
Overall, there is a general decrease in the expression of genes
involved with basic growth and metabolic processes in all
Figure 21. Expression of representative genes in the facial prominences II: MdP and MxP-specific. Whole mount in situ expression
analysis of: Ifitm3 (A, B); Lrba (C–E); AI606473 (F, G); A930038C07Rik (H–K); Gpr50 (L–N); Rgs5 (O–Q); and AV026068 (R–T); showing lateral (A, C, E, F, H, K,
L, O, T) or ventral (B, D, G, I, J, M, N, P–S) views of E10.5 (A–D, F–I, L, M, O, P, R) or E11.5 (E, J, K, N, Q, S, T) mice. Abbreviations: e, eye; fl, forelimb bud;
fn, frontonasal prominence; h, hyoid arch; hl, hindlimb bud; l, lateral nasal prominence; m, medial nasal prominence; md, mandibular prominence;
mg, midgut; ov, otic vesicle; p, nasal pit; rp, Rathke’s pouch; t, telencephalon; x, maxillary prominence.
doi:10.1371/journal.pone.0008066.g021
Orofacial Gene Expression
PLoS ONE | www.plosone.org 26 December 2009 | Volume 4 | Issue 12 | e8066prominences between E10.5–E12.5. There is also down-regulation
of genes that are associated with the maintenance of progenitor
cell function, including Igdcc3 (Punc), Sall4, a subset of polycomb
genes, and certain DNA and chromatin modifying components.
Balanced against the down-regulation of genes involved in growth,
replication, and progenitor cell function, there is corresponding
up-regulation of transcripts derived from genes involved in
differentiation in the MdP, MxP and FNP. These coordinated
changes in gene expression in the three prominences are
accompanied by other unique patterns of gene expression in each
location that presage the distinct tissues generated by each
prominence. Thus, the FNP is distinguished by the expression of
genes associated with development of the olfactory placodes and
neurogenesis in the olfactory epithelium. In contrast, transcripts
from genes involved in vasculogenesis and muscle development are
prominent in the MdP correlating with the development of the
branchial arch arteries and tongue from the first arch [3,4,55].
Fundamental differences in gene expression between the three
prominences are already apparent at E10.5, the earliest time point
analyzed. Thus, early in facial development, unique molecular
programs are employed in each prominence that presumably drive
the different fates of these three structures. The most robust
prominence-specific expression differences occur in the MdP and
FNP, with a more limited number of expression profiles that are
distinctive for the MxP (see Figure 22A, B). The FNP, in particular,
shows the most distinctive gene expression profile with increased
expression of many genes involved in transcription (e.g. Dmrta2,
GeneID: 242620; and Dmrt3, GeneID: 240590), signaling (e.g.
Cxcl13, GeneID: 55985; Cxcr4, GeneID: 12767; Fezf1, GeneID:
73191; Irs4, GeneID: 16370; and S100a6, GeneID: 20200) and also
retinoid metabolism (Aldh1a3, GeneID: 56847). Conversely, com-
pared withthe otherprominences, the FNPhasreduced RNAlevels
for several transcription factors (e.g. Barx1 GeneID: 12022; and
Vgll2, GeneID: 215031) as well as Frzb (GeneID: 20378), Lrba and
Gap43 (GeneID: 14432). The MdP and MxP also have a unique
arrangement of genes that are either expressed at higher or lower
levels in either of these individual prominences. We note that
another group of genes exhibit a unique level of expression in each
of the prominences, possibly reflecting a spatial code of graded
expression that helps to impart identity (Figure 22C).
Overall, genes encoding transcription factors and molecules
involved in signal transduction figure heavily in prominence-
specific differences at the onset of facial outgrowth. Considered
together, the combinatorial repertoire of transcription factors
present in each prominence by E10.5 will certainly generate
unique and highly specific patterns of gene expression. Moreover,
each prominence is primed to express different signal transduction
components and will therefore respond differently to any available
signaling molecules. Together, these differences undoubtedly
provide the basis for the elaboration of individual FNP, MxP,
and MdP identities as development proceeds. Given that
fundamental differences in gene expression in these prominences
are already apparent by E10.5, it will be important to extend these
studies to even earlier time points to determine when specific
patterns are established. However, the extremely small size of
tissue samples that can be prepared from the FNP and MxP prior
to E10.5 would provide lower quality bioinformatic information
than presented in the current analysis.
The data we have obtained can be employed to predict and
interpret regulatory networks, nodal points, and gene interactions
shaping the mammalian face [55,73]. One unexpected finding
from our analyses was that several genes expressed in the
developing face are organized into bidirectional transcription
units (Figure S10). Such paired genes have similar expression
Figure 22. Significant expression differences exist among the
facial prominences at E10.5. Heatmaps of (A) genes showing ,2-
fold or greater differences in expression in the three prominences at
E10.5; (B) the transcription factors within this dataset; (C) genes
showing graded expression in the three prominences. The genes
analyzed are shown on the left and the prominences at the bottom. For
each gene, the data was first averaged over all seven replicates at E10.5
for each probe set on the array and then averaged across all probe sets
representing the gene, where probe sets called ‘Absent’ across all 105
arrays were previously discarded. The red-blue color of the heatmap
indicates the range of the resulting data for each gene, scaled relative
to the mean of the three values at E10.5 in the three prominences.
doi:10.1371/journal.pone.0008066.g022
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sequences. Recently, a bidirectional transcription unit was noted
for another gene-pair expressed in the face, Foxl2 and
E330015D05 (GenBank gi: 74228500), as well as for one of the
pairs we describe Pou3f3 and 2610017I09Rik [74]. In all these
instances the gene pairs are unrelated at the sequence level and are
transcribed divergently. Nevertheless, the close linkage of two
genes expressed in similar domains during facial development is
reminiscent of the paired, although convergently transcribed,
Dlx1/2, Dlx3/4, and Dlx5/6 genes [26]. These new findings raise
the possibility that such paired and/or bidirectional transcription
units may be a more common feature of gene expression in the
face than was previously appreciated. At present, the functional
consequence of this arrangement for many of these gene-pairs
remains unclear, but the possibility that targeted mutation of one
gene could affect expression or function of the other partner in the
transcription unit should be considered.
Recent studies have revealed links between facial morphology
and the action of multiple signal transduction pathways including
those involving Calcium ion, Fgf, Shh, BMP, and Wnt signals
[2,75]. Mining this large expression dataset should assist in
identifying associated components of these signaling pathways that
function in orofacial formation. On one level, individual genes can
be prioritized for analysis by gene knockdown in animal model
systems, but we also hope that the dataset can be utilized to revisit
previously generated gene knockouts in mice to screen for subtle
defects in orofacial formation and function that may not have been
recorded. Further, the available information may help to predict
combinations of genes that need to be targeted simultaneously to
impact orofacial development due to redundancy. Conversely, it
may be possible to generate homeotic transformations by altering
key gene expression patterns in one prominence to match a
different facial region. In a wider context, the data can also be
utilized in conjunction with microarray analyses performed on
orofacial development in other species, particularly human and
chick, to study species-specific differences in gene expression that
may underlie variation in vertebrate facial morphology [76,77].
Finally, the information we have obtained can also be utilized as a
baseline dataset that can be employed to identify gene expression
differences that occur in various mouse models of orofacial clefting
or other types of craniofacial dysmorphology.
Supporting Information
Figure S1 Assessment of RNA quality prior to microarray
analysis. A representative RT-PCR analysis on RNA isolated from
the FNP and MxP for four genes expected to be expressed in the
facial prominences (Tcfap2a, Bmp2, Dlx2, and Gsc). The sizes of
the expected products are shown next to the gene name. Zic3 is
expressed in forebrain tissue and its absence from the facial
prominence RNA samples following RT-PCR and gel electro-
phoresis was indicative of lack of contamination by CNS tissue.
The intact mouse head sample serves as a positive control for all
RT-PCR reactions. MKS, DNA ladder size markers.
Found at: doi:10.1371/journal.pone.0008066.s001 (1.31 MB TIF)
Figure S2 Spatial and Temporal Specific Gene Expression
Differences in the Developing Facial Prominences. A. A bar graph
illustrating the number of probes showing significant differences
between the two prominences indicated at a given time point
assessed using limma based on a 1% false discovery rate and a 2-
fold expression difference. B. Bar graph showing the number of
probe sets showing a significant increase or decrease between
adjacent time points within a particular prominence using the
same statistical criteria employed in A.
Found at: doi:10.1371/journal.pone.0008066.s002 (0.56 MB TIF)
Figure S3 Analysis of Signal values among replicates. A–B.
Boxplot of logarithm of mean and standard deviation of the Signal
values among seven replicates. The horizontal axis shows the
sample index 1–15 corresponding to time points E10.5 to E12.5 in
MdP (1–5), MxP (6–10) and FNP (11–15) respectively. Boxes have
lines at the lower quartile, median and upper quartile values while
whiskers extending from the box show the remaining data range.
The consistency of box size and median level across all boxes
shows reproducibility among replicates in all prominences and at
all time points. C–D. Worst (C) and best (D) replication among a
pair of replicates. Each dot represents the Signal value for a probe.
The identity of the sample is given along the axes and coefficient r
measures linear correlation. The wide and slim spread of points in
each plot demonstrates high and low quality replication,
respectively.
Found at: doi:10.1371/journal.pone.0008066.s003 (0.37 MB TIF)
Figure S4 Heatmap of collagen and collagen processing enzyme
gene expression. The genes analyzed are shown on the left, the
prominences at the top, the time points at the bottom and the class
of profile at the right. The grey line marks the separation of up-
regulated collagen genes from processing enzymes. Data for a
given gene is the average of data for all probe sets representing that
gene (first averaged within the seven biological replicates per time
point) and then the resulting vector is scaled to have a mean of
zero and a magnitude of one. Blue and red indicate low and high
expression levels, respectively.
Found at: doi:10.1371/journal.pone.0008066.s004 (0.87 MB TIF)
Figure S5 Heatmap of extracellular matrix component gene
expression. The genes analyzed are shown on the left, the
prominences at the top, the time points at the bottom and the class
of profile at the right. Data for a given gene is the average of data
for all probe sets representing that gene (first averaged within the
seven biological replicates per time point) and then the resulting
vector is scaled to have a mean of zero and a magnitude of one.
Blue and red indicate low and high expression levels, respectively.
VAR, variable profile but still coordinately regulated.
Found at: doi:10.1371/journal.pone.0008066.s005 (1.04 MB TIF)
Figure S6 Heatmap of transcription factors coordinately
regulated in all prominences. The genes analyzed are shown on
the left, the prominences at the top, the time points at the bottom
and the class of profile at the right. Data for a given gene is the
average of data for all probe sets representing that gene (first
averaged within the seven biological replicates per time point) and
then the resulting vector is scaled to have a mean of zero and a
magnitude of one. Blue and red indicate low and high expression
levels, respectively. VAR, variable profile but still coordinately
regulated.
Found at: doi:10.1371/journal.pone.0008066.s006 (0.59 MB TIF)
Figure S7 Heatmap of transcription factors highly expressed in
a single prominence. The genes analyzed are shown on the left, the
prominences at the top, the time points at the bottom and the class
of profile at the right. Data for a given gene is the average of data
for all probe sets representing that gene (first averaged within the
seven biological replicates per time point) and then the resulting
vector is scaled to have a mean of zero and a magnitude of one.
Blue and red indicate low and high expression levels, respectively.
HIGH, expression is generally higher throughout the time course
than in the other prominences, although not necessarily increasing
or decreasing.
Found at: doi:10.1371/journal.pone.0008066.s007 (3.14 MB TIF)
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two of the three prominences. The genes analyzed are shown on
the left, the prominences at the top, the time points at the bottom
and the class of profile at the right. Data for a given gene is the
average of data for all probe sets representing that gene (first
averaged within the seven biological replicates per time point) and
then the resulting vector is scaled to have a mean of zero and a
magnitude of one. Blue and red indicate low and high expression
levels, respectively. HIGH, expression is generally higher through-
out the time course in two of the three prominences, although not
necessarily increasing or decreasing.
Found at: doi:10.1371/journal.pone.0008066.s008 (2.68 MB TIF)
Figure S9 (A). Biological verification of the dataset using the
novel genes associated with orofacial expression as well as the
previously characterized linked genes. Raw data for the genes and
associated probe sets (left) indicated at the five time points in the
three prominences. (B). Corresponding heatmap showing the
expression data for each probe scaled such that the vector of log2
expression values for a probe (averaged among replicate samples
per time point) has a mean of zero and a magnitude of one. Red
and blue indicate high and low expression, respectively.
Found at: doi:10.1371/journal.pone.0008066.s009 (1.16 MB TIF)
Figure S10 Bidirectional transcription units associated with
orofacial gene expression. The analysis of novel genes associated
with expression in the facial prominences indicated that at least
three mouse genes displaying similar expression patterns to known
genes were also closely linked to them in the mouse genome and
transcribed in the opposite direction. These finding suggest that
they share common cis-acting sequences responsible for their
similar patterns of gene expression. The distances between the
pairs 2610017I09Rik and Pou3f3, AI606473 and Lhx8, and
AV026068 and Hand2 are approximately 2.3 kb, 260 bp and 60–
220 bp respectively. A bidirectional arrangement of these gene
pairs is also conserved in the human genome (human cDNA or
gene names are shown in blue), with the following caveats. The
AK096498 (Homo sapiens cDNA FLJ39179 fis, clone
OCBBF2004147) mRNA initiates ,4 kb upstream of POU3F3,
but other spliced transcripts from this locus begin only ,2.3 kb
upstream. The human RefSeq for LHX8 contains two upstream
exons that are not present in the mouse RefSeq. The opposite
strand transcript from AK055631 would therefore initiate from
within the second intron of LHX8. However, we suspect (based on
a protein sequence comparison between mammalian species) that
the human RefSeq may have been derived from an atypical
transcript and that the arrangement we have noted in the mouse
may also hold in the human genome. Information was obtained
from NCBI (http://www.ncbi.nlm.nih.gov/) and the UCSC
genome browser (http://genome.ucsc.edu/) using the Mouse July
2007 (mm9) Assembly and the Human Feb. 2009 (hg19)
Assembly.
Found at: doi:10.1371/journal.pone.0008066.s010 (0.03 MB
DOC)
Table S1 Gene specific PCR primer sequences and PCR
product sizes.
Found at: doi:10.1371/journal.pone.0008066.s011 (0.26 MB
DOC)
Table S2 Trajectory Clustering Analysis. Trajectory clustering
was applied using the limma-derived p-values with fdr=0.01. Each
line lists a specific over-represented GO Biological Process,
Molecular Function, or InterPro term and the trajectory clusters
within each prominence in which that term was over-represented.
The trajectory profile is given as a sequence of ‘\’ for Decrease,
‘-’for Flat, and ‘/’ for Increase between consecutive time points. The
prominence is specified as mandibular (MdP), maxillary (MxP) and
frontonasal(FNP).Over-representationwastestedusingthebinomial
distribution,applyingtheBenjaminiandHochberg(6)falsediscovery
rate multiple comparison correction at a cutoff of 0.05.
Found at: doi:10.1371/journal.pone.0008066.s012 (0.06 MB
XLS)
Table S3 Functional Category Analysis A–D. Details of
Functional Category Analysis for Predominantly Decreasing
Trajectories (With 2-Fold Change Requirement). Using the
Trajectory Clustering Algorithm with limma-derived p-values
and an fdr of 0.01 (2-fold change requirement), the combined set
of all MGI identifiers represented by probes in clusters with at least
two decreases and no increases was tested for over-representation
of annotations. For each term, values used in calculating the
binomial distribution are given as follows for each of the three
prominences (P for mandibular (MdP), X for maxillary (MxP) and
N for frontonasal (FNP)): H - whether the category was called
significant at the (unadjusted) 0.05 level with the binomial
distribution, N - number of MGI identifiers annotated to any
category over the set of all MGI identifiers, M - number of MGI
identifiers annotated to the given category, K - number of MGI
identifiers tested in the list, and x - number of MGI identifiers in
the list annotated to the given category. Annotations for (A) GO
Biological Process (GOBP); (B) GO Molecular Function (GOMF);
(C) InterPro; and (D) KEGG. E–J. Details of Functional Category
Analysis for Predominantly Decreasing Trajectories (No Fold
Change Requirement). Using the Trajectory Clustering Algorithm
with limma-derived p-values and an fdr of 0.01 (no fold change
requirement), the combined set of all MGI identifiers represented
by probes in clusters with at least two decreases and no increases
was tested for over-representation of annotations. For each term,
values used in calculating the binomial distribution are given as
follows for each of the three prominences (P for mandibular
(MdP), X for maxillary (MxP) and N for frontonasal (FNP)): H -
whether the category was called significant at the (unadjusted) 0.05
level with the binomial distribution, N - number of MGI identifiers
annotated to any category over the set of all MGI identifiers, M -
number of MGI identifiers annotated to the given category, K -
number of MGI identifiers tested in the list, and x - number of
MGI identifiers in the list annotated to the given category.
Annotations for (E) GO Biological Process (GOBP); (F) GO
Molecular Function (GOMF); (G) InterPro; (H) KEGG; and (J)
MGI Phenotype. K–P. Details of Functional Category Analysis for
Predominantly Increasing Trajectories (With 2-Fold Change
Requirement). Using the Trajectory Clustering Algorithm with
limma-derived p-values and an fdr of 0.01 (2-fold change
requirement), the combined set of all MGI identifiers represented
by probes in clusters with at least two increases and no decreases
was tested for over-representation of annotations. For each term,
values used in calculating the binomial distribution are given as
follows for each of the three prominences (P for mandibular
(MdP), X for maxillary (MxP) and N for frontonasal (FNP)): H -
whether the category was called significant at the (unadjusted) 0.05
level with the binomial distribution, N - number of MGI identifiers
annotated to any category over the set of all MGI identifiers, M -
number of MGI identifiers annotated to the given category, K -
number of MGI identifiers tested in the list, and x - number of
MGI identifiers in the list annotated to the given category.
Annotations for (K) GO Biological Process (GOBP); (L) GO
Molecular Function (GOMF); (M) InterPro; (N) KEGG; and (P)
MGI Phenotype. Q–U. Details of Functional Category Analysis
for Predominantly Increasing Trajectories (No Fold Change
Requirement). Using the Trajectory Clustering Algorithm with
Orofacial Gene Expression
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requirement), the combined set of all MGI identifiers represented
by probes in clusters with at least two increases and no decreases
was tested for over-representation of annotations. For each term,
values used in calculating the binomial distribution are given as
follows for each of the three prominences (P for mandibular
(MdP), X for maxillary (MxP) and N for frontonasal (FNP)): H -
whether the category was called significant at the (unadjusted) 0.05
level with the binomial distribution, N - number of MGI identifiers
annotated to any category over the set of all MGI identifiers, M -
number of MGI identifiers annotated to the given category, K -
number of MGI identifiers tested in the list, and x - number of
MGI identifiers in the list annotated to the given category.
Annotations for (Q) GO Biological Process (GOBP); (R) GO
Molecular Function (GOMF); (S) InterPro; (T) KEGG; and (U)
MGI Phenotype.
Found at: doi:10.1371/journal.pone.0008066.s013 (0.36 MB
XLS)
Table S4 Details of Functional Category Analysis for Tissue
Specific Expression (With 2-Fold Change Requirement). Over-
representation of annotations was tested for MGI identifiers
represented among the set of 1506 probes with at least one
prominence-specific difference as determined by limma with
fdr=0.01 and requiring at least a 2-fold change. A prominence-
specific subset of the 1506 probes was created from probes
showing at least one increase in expression over the other two
prominences for the same time point, thereby excluding a probe
from a given prominence-specific list if it had the lowest expression
in that prominence of the three prominence. For each term, values
used in calculating the binomial distribution are given as follows
for each of the three prominences (P for mandibular (MdP), X for
maxillary (MxP) and N for frontonasal (FNP)): H - whether the
category was called significant at the (unadjusted) 0.05 level with
the binomial distribution, N - number of MGI identifiers
annotated to any category over the set of all MGI identifiers, M
- number of MGI identifiers annotated to the given category, K -
number of MGI identifiers tested in the list, and x - number of
MGI identifiers in the list annotated to the given category.
Annotations for (A) GO Biological Process (GOBP); (B) GO
Molecular Function (GOMF); (C) InterPro; (D) KEGG; and (E)
MGI Phenotype.
Found at: doi:10.1371/journal.pone.0008066.s014 (0.26 MB
XLS)
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